222 related articles for article (PubMed ID: 26585434)
1. COPD and risk of venous thromboembolism and mortality in a general population.
Børvik T; Brækkan SK; Enga K; Schirmer H; Brodin EE; Melbye H; Hansen JB
Eur Respir J; 2016 Feb; 47(2):473-81. PubMed ID: 26585434
[TBL] [Abstract][Full Text] [Related]
2. Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromsø Study.
Børvik T; Brækkan SK; Evensen LH; Brodin EE; Morelli VM; Melbye H; Hansen JB
Thromb Haemost; 2020 Mar; 120(3):477-483. PubMed ID: 31887782
[TBL] [Abstract][Full Text] [Related]
3. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population.
Ellingsen TS; Lappegård J; Skjelbakken T; Brækkan SK; Hansen JB
Thromb Haemost; 2015 Jan; 113(1):193-200. PubMed ID: 25274492
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Enga KF; Jorde R; Brodin EE; Svartberg J; Brækkan SK; Hansen JB
Eur J Endocrinol; 2015 Jul; 173(1):83-90. PubMed ID: 25899580
[TBL] [Abstract][Full Text] [Related]
5. Body height and risk of venous thromboembolism: The Tromsø Study.
Braekkan SK; Borch KH; Mathiesen EB; Njølstad I; Wilsgaard T; Hansen JB
Am J Epidemiol; 2010 May; 171(10):1109-15. PubMed ID: 20418276
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
7. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
[TBL] [Abstract][Full Text] [Related]
8. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
9. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
[TBL] [Abstract][Full Text] [Related]
10. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism and subsequent permanent work-related disability.
Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between airflow limitation and recurrence of venous thromboembolism among cancer patients with pulmonary embolism.
Shin SH; Kang D; Cho J; Chang H; Kim MS; Lee SY; Lee H; Kim H; Kim DK; Kim EK; Park HY
Int J Chron Obstruct Pulmon Dis; 2018; 13():937-943. PubMed ID: 29593386
[TBL] [Abstract][Full Text] [Related]
13. Weight Change and Risk of Venous Thromboembolism: The Tromsø Study.
Horvei LD; Brækkan SK; Hansen JB
PLoS One; 2016; 11(12):e0168878. PubMed ID: 27997594
[TBL] [Abstract][Full Text] [Related]
14. Heart healthy diet and risk of myocardial infarction and venous thromboembolism. The Tromsø Study.
Hansen-Krone IJ; Enga KF; Njølstad I; Hansen JB; Braekkan SK
Thromb Haemost; 2012 Sep; 108(3):554-60. PubMed ID: 22739999
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
16. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study.
Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW
Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286
[TBL] [Abstract][Full Text] [Related]
17. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
[TBL] [Abstract][Full Text] [Related]
18. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.
Enga KF; Braekkan SK; Hansen-Krone IJ; le Cessie S; Rosendaal FR; Hansen JB
J Thromb Haemost; 2012 Oct; 10(10):2068-74. PubMed ID: 22882779
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study.
Le Mao R; Tromeur C; Bazire A; Gouillou M; Guegan M; Lacut K; Delluc A; Mottier D; Leroyer C; Couturaud F
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
